Poseida Therapeutics to Present at Stifel 2023 Tailoring Genes: Genetic Medicines DayPRNewsWire • 05/23/23
Poseida Therapeutics to Present at 31st Congress of the International Society on Thrombosis and HaemostasisPRNewsWire • 05/22/23
Poseida Therapeutics Presents Encouraging Preclinical Data Across its Gene Therapy Programs at the American Society for Gene and Cell Therapy 2023 Annual MeetingPRNewsWire • 05/18/23
Poseida Therapeutics, Inc. (PSTX) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/10/23
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2023PRNewsWire • 05/09/23
Poseida Therapeutics Announces Multiple Presentations at the American Society of Gene and Cell Therapy 26th Annual MeetingPRNewsWire • 05/02/23
Poseida Therapeutics, Inc. (PSTX) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/10/23
Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2022PRNewsWire • 03/09/23
Poseida Therapeutics Appoints Five New Members to Its Gene Therapy Scientific Advisory BoardPRNewsWire • 03/01/23
Poseida Therapeutics Hosts Third Annual Virtual R&D Day Highlighting Novel Pipeline Assets and Latest Technology InnovationsPRNewsWire • 02/22/23
Poseida Therapeutics to Present at H.C. Wainwright Cell Therapy Virtual ConferencePRNewsWire • 02/14/23
Poseida Therapeutics: New Allogeneic Therapies, Leveraging Non-Viral EngineeringSeeking Alpha • 02/06/23
Poseida Therapeutics, Inc. (PSTX) is on the Move, Here's Why the Trend Could be SustainableZacks Investment Research • 01/27/23
Recent Price Trend in Poseida Therapeutics, Inc. (PSTX) is Your Friend, Here's WhyZacks Investment Research • 01/10/23
Poseida Therapeutics, Inc. (PSTX) Is a Great Choice for 'Trend' Investors, Here's WhyZacks Investment Research • 12/15/22
Poseida Therapeutics Presents Preclinical Data from P-FVIII-101 Gene Therapy for Hemophilia A at the 64th ASH Annual Meeting & ExpositionPRNewsWire • 12/11/22
Wall Street Analysts See an 189% Upside in Poseida Therapeutics, Inc. (PSTX): Can the Stock Really Move This High?Zacks Investment Research • 12/06/22